NASDAQ: AVLN
Avalyn Pharma Inc Earnings Dates, Reports, Calls

Avalyn Pharma earnings were -$85.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest AVLN earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AVLN reported annual earnings of -$85.2M, with 71.3% growth.

AVLN earnings history

Current Revenue
$0.0
Current Earnings
-$85.2M
Current Profit Margin
0%

AVLN Return on Equity

Insufficient data to display

AVLN Return on Assets

Current Company
-62.3%
Current Industry
-9.6%

Be the first to know when AVLN announces earnings.

AVLN Return on Capital Employed

Current Company
-63.21%
Current Industry
-3.7%

AVLN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ACHV-$53.60M-$54.65MN/A-$1.25
AAPG-$160.60M-$182.22MN/A-$2.05
AARD-$57.18M-$57.59MN/A-$2.93
ABUS-$33.04M-$33.50MN/A-$0.17
ABVX-$249.93M-$386.32MN/A-$5.55

Avalyn Pharma Earnings Reports & History FAQ

What were Avalyn Pharma's earnings last quarter?

Avalyn Pharma (NASDAQ: AVLN) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total AVLN earnings for the quarter were N/A. In the same quarter last year, Avalyn Pharma's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Avalyn Pharma stock.

Is Avalyn Pharma profitable or losing money?

As of the last Avalyn Pharma earnings report, Avalyn Pharma is currently losing money. Avalyn Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$85.20 million, a 71.28% increase year over year.

What was AVLN's earnings growth in the past year?

As of Avalyn Pharma's earnings date in Q2 2026, Avalyn Pharma's earnings has grown year over year. AVLN earnings in the past year totalled -$85.20 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.